Details for New Drug Application (NDA): 040131
✉ Email this page to a colleague
NDA 040131 describes EDROPHONIUM CHLORIDE, which is a drug marketed by Hospira and Watson Labs and is included in three NDAs. Additional details are available on the EDROPHONIUM CHLORIDE profile page.
The generic ingredient in EDROPHONIUM CHLORIDE is edrophonium chloride. There are three drug master file entries for this compound. Additional details are available on the edrophonium chloride profile page.
The generic ingredient in EDROPHONIUM CHLORIDE is edrophonium chloride. There are three drug master file entries for this compound. Additional details are available on the edrophonium chloride profile page.
Summary for 040131
| Tradename: | EDROPHONIUM CHLORIDE |
| Applicant: | Hospira |
| Ingredient: | edrophonium chloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040131
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
| Approval Date: | Feb 24, 1998 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
